Arax Advisory Partners’s Astrana Health ASTH Stock Holding History

Arax Advisory Partners’s Portfolio ASTH Stock Details ASTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$45.1K	Buy	+972	New	+$35K	﹤0.01%	3356
2026 Q1	–	Sell	-206	Closed	-$5.11K	–	4401
2025 Q4	$5.11K	Sell	206 -2	-1%	-$53	﹤0.01%	2838
2025 Q3	$5.9K	Buy	208 +155	+292%	+$4.2K	﹤0.01%	2814
2025 Q2	$1.32K	Buy	+53	New	+$1.49K	﹤0.01%	2693
2025 Q1	–	Sell	-16	Closed	-$505	–	3091
2024 Q4	$505	Sell	16 -62	-79%	-$2.94K	﹤0.01%	2324
2024 Q3	$4.52K	Hold	78	–	–	﹤0.01%	1761
2024 Q2	$3.16K	Buy	+78	New	+$3.09K	﹤0.01%	1804

Other funds holding ASTH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

325 Capital New York $419M AUM 75.74% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Arax Advisory Partners's ASTH Position: Q2 2026 in Review

Arax Advisory Partners opened a new position in Astrana Health (ASTH) in Q2 2026: 972 shares worth $45.1K. The stake represents ﹤0.01% of the portfolio and ranks #3356 among its holdings. This is a return to the name: Arax Advisory Partners previously reported a position in ASTH as recently as Q4 2025.

Arax Advisory Partners first reported a position in ASTH in Q2 2024 and has held it in 7 quarters since. 209 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.

Arax Advisory Partners held 972 shares of Astrana Health worth $45.1K as of Q2 2026.
Astrana Health was a new Arax Advisory Partners position in Q2 2026.
Astrana Health made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #3356 holding.
Arax Advisory Partners first reported a position in Astrana Health in Q2 2024 and has held it in 7 quarters since.
209 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.